Juan Andres - 27 Aug 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Technical Operations and Quality Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
27 Aug 2021
Transactions value $
-$7,280,350
Form type
4
Filing time
31 Aug 2021, 16:49:54 UTC
Previous filing
27 Aug 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $61.1K +5K $12.21* 5K 27 Aug 2021 Direct F1
transaction MRNA Common Stock Sale -$1.99M -5K -100% $398.12 0 27 Aug 2021 Direct F1
transaction MRNA Common Stock Options Exercise $61.1K +5K $12.21* 5K 30 Aug 2021 Direct F1
transaction MRNA Common Stock Options Exercise $122K +10K +200% $12.21* 15K 30 Aug 2021 Direct F1
transaction MRNA Common Stock Sale -$5.53M -15K -100% $368.93 0 30 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -5K -1.54% $0.00 320K 27 Aug 2021 Common Stock 5K $12.21 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -5K -1.56% $0.00 315K 30 Aug 2021 Common Stock 5K $12.21 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -10K -3.18% $0.00 305K 30 Aug 2021 Common Stock 10K $12.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020, and amended on May 12, 2021.
F2 This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer